Wallace Owen B. 4
4 · Monte Rosa Therapeutics, Inc. · Filed Mar 2, 2022
Insider Transaction Report
Form 4
Wallace Owen B.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+117,450→ 117,450 totalExercise: $13.41Exp: 2032-02-29→ Common Stock (117,450 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter.